Enhanced Recovery Pathways and Their Influence on Anesthetic Resource Utilization

Abstract

Enhanced recovery after surgery (ERAS) pathways have expanded from their colorectal origins into cardiac, orthopedic, spine, and nonoperating-room anesthesia settings, and the anesthetic components of these pathways now largely determine whether the promised resource savings are realized. This review examines how opioid-sparing multimodal anesthesia, regional and neuraxial techniques, modified postanesthesia care unit discharge criteria, and goal-directed fluid management specifically affect anesthesia-controlled resources such as opioid consumption, recovery-room and intensive care unit time, operating room turnover, and staffing needs. Across colorectal, cardiac, and total joint arthroplasty pathways, opioid-sparing anesthesia and updated PACU discharge criteria are consistently linked to shorter recovery-room or intensive care unit time, while goal-directed fluid therapy reduces complication-driven costs even when it does not shorten the case itself. These benefits are conditional on faithful, cross-disciplinary implementation and on upfront investment in regional anesthesia capacity, hemodynamic monitoring, and data infrastructure that individual efficacy trials rarely account for. We conclude that the anesthetic components of ERAS pathways reliably improve resource predictability and reduce opioid and recovery-unit burden when implemented as designed, though the magnitude of benefit varies by surgical service and local infrastructure and remains an active area of precision-medicine refinement.